Yogindra Persaud

2.8k total citations
12 papers, 818 citations indexed

About

Yogindra Persaud is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Yogindra Persaud has authored 12 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Hematology and 4 papers in Oncology. Recurrent topics in Yogindra Persaud's work include Melanoma and MAPK Pathways (4 papers), Acute Lymphoblastic Leukemia research (2 papers) and Computational Drug Discovery Methods (2 papers). Yogindra Persaud is often cited by papers focused on Melanoma and MAPK Pathways (4 papers), Acute Lymphoblastic Leukemia research (2 papers) and Computational Drug Discovery Methods (2 papers). Yogindra Persaud collaborates with scholars based in United States, Russia and Canada. Yogindra Persaud's co-authors include Barry S. Taylor, Christine A. Pratilas, David B. Solit, Agnès Viale, Ensar Halilovic, Neal Rosen, Gideon Bollag, Madhavi Tadi, Weiqing Wang and Eric W. Joseph and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Cancer Research.

In The Last Decade

Yogindra Persaud

10 papers receiving 811 citations

Peers

Yogindra Persaud
Arthur Groy United States
Marian M. Deuker United States
Kelly E. Fisher United States
Eli Wallace United States
Zoi Karoulia United States
Neilawattie M. Torres United States
Kimberly N. Smitheman United States
Fumi Kinose United States
Mary Ellen Simcox United States
Laura M. Bruzek United States
Arthur Groy United States
Yogindra Persaud
Citations per year, relative to Yogindra Persaud Yogindra Persaud (= 1×) peers Arthur Groy

Countries citing papers authored by Yogindra Persaud

Since Specialization
Citations

This map shows the geographic impact of Yogindra Persaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yogindra Persaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yogindra Persaud more than expected).

Fields of papers citing papers by Yogindra Persaud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yogindra Persaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yogindra Persaud. The network helps show where Yogindra Persaud may publish in the future.

Co-authorship network of co-authors of Yogindra Persaud

This figure shows the co-authorship network connecting the top 25 collaborators of Yogindra Persaud. A scholar is included among the top collaborators of Yogindra Persaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yogindra Persaud. Yogindra Persaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Leonard, Alexis, Akshay Sharma, Yogindra Persaud, et al.. (2024). Motixafortide for Hematopoietic Stem and Progenitor Cell Mobilization and Collection in Sickle Cell Disease. Blood. 144(Supplement 1). 2100.1–2100.1. 2 indexed citations
2.
Hu, Zhongbo, Yogindra Persaud, & Sanjay Ahuja. (2024). A systematic review and meta-analysis of the effectiveness of primary thromboprophylaxis in acute lymphoblastic leukemia during early-phase therapy including asparaginase or its prolonged form. Critical Reviews in Oncology/Hematology. 197. 104347–104347. 1 indexed citations
3.
Persaud, Yogindra, et al.. (2024). Current and emerging drug treatment strategies to tackle sickle cell anemia. Expert Opinion on Emerging Drugs. 29(4). 327–346. 1 indexed citations
4.
Persaud, Yogindra, Belinda N. Mandrell, Akshay Sharma, et al.. (2023). Attitudes toward COVID‐19 vaccine among pediatric patients with sickle cell disease and their caregivers. Pediatric Blood & Cancer. 70(5). e30274–e30274. 6 indexed citations
5.
Persaud, Yogindra, Victoria Okhomina, Andrew M. Heitzer, et al.. (2023). The Impact of Socio-Economic Determinants of Health on PedsQL and Pain Outcomes Among Individuals with Sickle Cell Disease. Blood. 142(Supplement 1). 250–250.
6.
Persaud, Yogindra, et al.. (2020). Bortezomib treatment of steroid‐refractory Evans syndrome in children. Pediatric Blood & Cancer. 67(12). e28725–e28725. 4 indexed citations
7.
Persaud, Yogindra, et al.. (2020). Childhood B-Cell Acute Lymphoblastic Leukemia Following SARS CoV-2 Infection: A Potential Second “Hit” in Leukemogenesis. Journal of Pediatric Hematology/Oncology. 43(8). e1241–e1243. 8 indexed citations
8.
García-Rendueles, María E.R., Julio C. Ricarte‐Filho, Brian R. Untch, et al.. (2015). NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition. Cancer Discovery. 5(11). 1178–1193. 99 indexed citations
9.
Poulikakos, Poulikos I., Yogindra Persaud, Manickam Janakiraman, et al.. (2011). Abstract LB-419: An in-frame deletion in the N-terminal regulatory domain of BRAF(V600E) causes resistance to the RAF inhibitor PLX4032. Cancer Research. 71(8_Supplement). LB–419.
10.
Persaud, Yogindra, Christine A. Pratilas, Barry S. Taylor, et al.. (2011). Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring V600EBRAF. Oncogene. 31(4). 446–457. 153 indexed citations
11.
Joseph, Eric W., Christine A. Pratilas, Poulikos I. Poulikakos, et al.. (2010). The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner. Proceedings of the National Academy of Sciences. 107(33). 14903–14908. 349 indexed citations
12.
Pratilas, Christine A., Aphrothiti J. Hanrahan, Ensar Halilovic, et al.. (2008). Genetic Predictors of MEK Dependence in Non–Small Cell Lung Cancer. Cancer Research. 68(22). 9375–9383. 195 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arthur Groy Breakdown of academic impact, for papers by Marian M. Deuker Breakdown of academic impact, for papers by Kelly E. Fisher Breakdown of academic impact, for papers by Eli Wallace Breakdown of academic impact, for papers by Zoi Karoulia Breakdown of academic impact, for papers by Neilawattie M. Torres Breakdown of academic impact, for papers by Kimberly N. Smitheman Breakdown of academic impact, for papers by Fumi Kinose Breakdown of academic impact, for papers by Mary Ellen Simcox Breakdown of academic impact, for papers by Laura M. Bruzek
Rankless by CCL
2026